BMJ, doi: 10.1136/bmj.39224.494340.55, (Published 7 June 2007)

research-article

Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial

¹ Developmental Psychiatry Section, Department of Psychiatry, Cambridge University, Cambridge CB2 2AH, ² Junction Adolescent Unit, Scotforth, Lancaster, and Department of Psychiatry, University of Manchester, ³ Brookside Family Consultation Centre, Cambridge, and Department of Psychiatry, University of Cambridge, ⁴ Biostatistics Group, Division of Epidemiology and Health Sciences, Manchester University, Manchester, ⁵ Centre for the Economics of Mental Health, Institute of Psychiatry, London, ⁶ Clinical Psychology Unit, Department of Psychology, Sheffield University, Sheffield, ⁷ Cambridgeshire Primary Care Trust, Fulbourn, Cambridge, ⁸ Thorn Road Clinic, Halton, Cheshire, ⁹ Division of Psychiatry, University of Manchester, Manchester, ¹⁰ Academic Department of Child and Adolescent Psychiatry, University of Manchester, Booth Hall Children's Hospital, Blackley, Manchester, ¹¹ Department of Child and Adolescent Psychiatry, Manchester University, Royal Manchester Children's Hospital, Pendlebury, Manchester

Objective To determine whether a combination of a selective serotonin reuptake inhibitor (SSRIs) and cognitive behaviour therapy (CBT) together with clinical care is more effective in the short term than an SSRI and clinical care alone in adolescents with moderate to severe major depression.

Design Pragmatic randomised controlled superiority trial.

Setting 6 outpatient clinics in Manchester and Cambridge.

Participants 208 adolescents, aged 11-17, with moderate to severe major or probable major depression who had not responded to a brief initial intervention. Adolescents with suicidality, depressive psychosis, or conduct disorder were included.

Interventions 103 adolescents received an SSRI and routine care; 105 received an SSRI, routine care, and CBT. The trial lasted 12 weeks, followed by a 16 week maintenance phase.

Main outcome measures Change in score on the Health of the Nation outcome scales for children and adolescents (primary outcome) from baseline with 12 weeks as the primary and 28 weeks as the follow-up end point. Secondary measures were change in scores on the mood and feelings questionnaire, the revised children's depression rating scale, the children's global assessment scale, and the clinical global impression improvement scale.

Results At 12 weeks the treatment effect for the primary outcome was –0.64 (95% confidence interval –2.54 to 1.26, P=0.50). In a longitudinal analysis, there was no difference in effectiveness of treatment for the primary (average treatment effect 0.001, –1.52 to 1.52, P=0.99) or secondary outcome measures. On average there was a decrease in suicidal thoughts and self harm. There was no evidence of a protective effect of cognitive behaviour therapy on suicidal thinking or action. By 28 weeks, 57% were much or very much improved with 20% remaining unimproved.

Conclusions For adolescents with moderate to severe major depression there is no evidence that the combination of CBT plus an SSRI in the presence of routine clinical care contributes to an improved outcome by 28 weeks compared with the provision of routine clinical care plus an SSRI alone.

Trial registration Current Controlled Trials ISRCNT 83809224.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Should young people be given antidepressants? Yes

Andrew Cotgrove
BMJ 2007 335: 750. [Extract] [Full Text] [PDF]

Should young people be given antidepressants? No

Sami Timimi
BMJ 2007 335: 751. [Extract] [Full Text] [PDF]

Study was not a trial of antidepressants

Jon N Jureidini
BMJ 2007 335: 221. [Extract] [Full Text] [PDF]

Is everything you know wrong?

Douglas Kamerow
BMJ 2007 335: 0. [Extract] [Full Text]

Depression in adolescents

Philip Hazell
BMJ 2007 335: 106-107. [Extract] [Full Text] [PDF]

Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder

Richard Harrington, Jane Whittaker, Philip Shoebridge, and Fiona Campbell
BMJ 1998 316: 1559-1563. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• (2008). Practice Parameter for the Assessment and Treatment of Children and Adolescents With Depressive Disorders. Focus 6: 379-400 [Abstract] [Full text]  
• Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L, Lewis, G, Matthews, K, McAllister-Williams, R., Peveler, R., Scott, J, Tylee, A (2008). Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22: 343-396 [Abstract]  
• Norquist, G., McGuire, T. G., Essock, S. M. (2008). Cost-Effectiveness of Depression Treatment for Adolescents. Am. J. Psychiatry 165: 549-552 [Full text]  
• Barbui, C., Cipriani, A., Geddes, J. R (2008). Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data. Evid. Based Ment. Health 11: 34-35 [Full text]  
• Vitiello, B., Pearson, J. L. (2008). A Depressed Adolescent at High Risk of Suicidal Behavior. Am. J. Psychiatry 165: 323-328 [Full text]  
• Brent, D., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M., Vitiello, B., Ritz, L., Iyengar, S., Abebe, K., Birmaher, B., Ryan, N., Kennard, B., Hughes, C., DeBar, L., McCracken, J., Strober, M., Suddath, R., Spirito, A., Leonard, H., Melhem, N., Porta, G., Onorato, M., Zelazny, J. (2008). Switching to Another SSRI or to Venlafaxine With or Without Cognitive Behavioral Therapy for Adolescents With SSRI-Resistant Depression: The TORDIA Randomized Controlled Trial. JAMA 299: 901-913 [Abstract] [Full text]  
• James, A. (2008). Pharmacotherapy and child psychiatry: is there a way forward?: INVITED COMMENTARY ON... CHILD PSYCHIATRY AND ITS RELATIONSHIP WITH THE PHARMACEUTICAL INDUSTRY. Adv. Psychiatr. Treat. 14: 10-16 [Abstract] [Full text]  
• Byford, S., Barrett, B., Roberts, C., Wilkinson, P., Dubicka, B., Kelvin, R. G., White, L., Ford, C., Breen, S., Goodyer, I. (2007). Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression. Br. J. Psychiatry 191: 521-527 [Abstract] [Full text]  
• Dubicka, B, Wilkinson, P (2007). Evidence-based treatment of adolescent major depression. Evid. Based Ment. Health 10: 100-102 [Full text]  
• Cotgrove, A. (2007). Should young people be given antidepressants? Yes. BMJ 335: 750-750 [Full text]  
• Timimi, S. (2007). Should young people be given antidepressants? No. BMJ 335: 751-751 [Full text]  
• Jureidini, J. N (2007). Study was not a trial of antidepressants. BMJ 335: 221-221 [Full text]  
• Hazell, P. (2007). Depression in adolescents. BMJ 335: 106-107 [Full text]  

Rapid Responses:

Read all Rapid Responses

Not a trial of antidepressants

Jon N Jureidini
bmj.com, 18 Jun 2007 [Full text]

Response to Jureidni

Ian M Goodyer
bmj.com, 26 Jun 2007 [Full text]

Both groups had "combined treatment"

Diane Civic
bmj.com, 24 Jul 2007 [Full text]

Re: Both groups had "combined treatment"

Ian M Goodyer
bmj.com, 15 Aug 2007 [Full text]